Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 2,343 | 1,714 | 571 |
| Operating Income | -2,343 | -1,714 | -571 |
| Interest Expense | 35 | 42 | 51 |
| Other Income | -225 | -56 | -428 |
| Pre-tax Income | -2,603 | -1,812 | -1,050 |
| Net Income Continuous | -2,603 | -1,812 | -1,050 |
| Net Income | $-2,603 | $-1,812 | $-1,050 |
| EPS Basic Total Ops | -0.23 | -0.17 | -0.10 |
| EPS Basic Continuous Ops | -0.23 | -0.17 | -0.10 |
| EPS Diluted Total Ops | -0.23 | -0.17 | -0.10 |
| EPS Diluted Continuous Ops | -0.23 | -0.17 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.23 | N/A | N/A |
| EBITDA(a) | $-2,029 | $-1,498 | $-3 |